SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genentech (NYSE:DNA) formerly known as (NYSE:GNE)
An SI Board Since July 1999
Posts SubjectMarks Bans Symbol
250 46 0 DNA
Emcee:  esecurities(tm) Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
100deleted duplicatetuck-9/11/2006
99>>FDA requests additional data for Avastin approval (in advanced breast catuck-9/11/2006
98Rituxan Is Promising in MS Trial Message 22760703Doc Bones-8/29/2006
97Does this guys EVER spent few minutes for quick facts search ?? DNA : 2300 patenMiljenko Zuanic-7/14/2006
96Genentech Raises Full-Year Forecast On Strong Sales [WSJ] By DAVID P. HAMILTON Doc Bones-7/12/2006
95It seems that the business of taking people's money for cancer is one of theSkywatcher-7/11/2006
94Genentech's Profits Soar in 2Q Tuesday July 11, 4:34 pm ET By Paul Elias, Doc Bones-7/11/2006
93Avastin+chemo for pancreatic cancer does not meet endpoint.. Phase III Study ofzeta1961-6/27/2006
92Motley Fool has an interesting take here, based on the cash flow drain anticipattuck-4/12/2006
91Merrill (neutral): Risk Being Reflected; Still Neutral Though: 1Q06 EPS includitom pope-4/12/2006
90Genentech Profit Surges On Cancer-Drugs Sales [WSJ] By JIM CARLTON April 12, 20Doc Bones-4/12/2006
89360 Degrees of Genentech By TSC Staff 3/9/2006 12:14 PM EST URL: thestreet.com Doc Bones-3/10/2006
88. . . and people wonder why patients sometimes turn to "natural remedies&quSandcast;le-2/21/2006
87Avastin to cost $100,000 per year. baltimoresun.com What price to save a life?Edscharp-2/20/2006
86Pfizer > FDA Approves New Treatment for Gastrointestinal and Kidney Cancer TQualified Opinion-1/26/2006
85Amgen and Genentech Sign License Agreements For Antibody Patents Thursday Januarnigel bates-1/26/2006
84Another lawsuit related to marketing of Rituxan: >>PHILADELPHIA (AP) -- Atuck-1/11/2006
83Genentech Net Income Jumps 64% Cancer-Drug Performance Propels Earnings Boost; Doc Bones-1/11/2006
82Musings on DNA’s 2005 results and 2006 guidance: investorshub.comDewDiligence_on_SI-1/11/2006
81Genentech down on Avastin Breast data Justin Ferayorni TSCM 12/9/2005 9:51 AM EDoc Bones-12/9/2005
80Genentech to pay $230 million for cancer drug ... Genentech is to pay privatelyJohn McCarthy-12/2/2005
79More on that darn Cabilly patent: investorshub.comDewDiligence_on_SI-11/11/2005
78<i>>Later in the release they said "average patient improved"DewDiligence_on_SI-11/9/2005
77Data showed 94% and 96% stable or improved vision on different Lucentis doses. west57th-11/9/2005
76ANCHOR results are out; Lucentis does not stumble: >>SOUTH SAN FRANCISCO,tuck-11/7/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News